Patents by Inventor Oliver Bezencon

Oliver Bezencon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diazabicyclononene Derivatives and Use Thereof
    Publication number: 20080161313
    Abstract: The invention relates to a novel 3,9-diazabicycl?[3.3.1]nonene derivative of formula (I) and the enantiomers thereof and the use thereof as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including pharmaceutical compositions containing at least one compound of formula (I) or (I?) and especially their use as inhibitors of renin.(I).
    Type: Application
    Filed: January 26, 2006
    Publication date: July 3, 2008
    Applicant: ACTELION PHARMACEUTICALS LTD
    Inventors: Oliver Bezencon, Daniel Bur, Walter Fischli, Lubos Remen, Sylvia Richard-Bildstein, Thierry Sifferlen, Thomas Weller
  • Novel diazabicyclononene derivatives
    Publication number: 20060223795
    Abstract: The invention relates to novel 3,9-diazabicyclo[3.3.1]nonene derivatives and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors of renin.
    Type: Application
    Filed: April 26, 2004
    Publication date: October 5, 2006
    Inventors: Oliver Bezencon, Daniel Bur, Walter Fischli, Lubos Remen, Sylvia Richard-Bildstein, Thomas Weller, Thierry Sifferlen
  • 8-hydroxy-7-substituted quinolines as anti-viral agents
    Patent number: 6252080
    Abstract: The present invention provides for 8-hydroxy-7-substituted quinoline compounds such as formula IA These compounds are useful as anti-viral agents. Specifically, these compounds have anti-viral activity against the herpes virus, cytomegalovirus (CMV). Many of these compounds are also active against other herpes viruses, such as the varicella zoster virus, the Epstein-Barr virus, the herpes simplex virus and the human herpes virus type 8 (HHV-8).
    Type: Grant
    Filed: October 22, 1999
    Date of Patent: June 26, 2001
    Assignee: Pharmacia & UpJohn Company
    Inventors: Suvit Thaisrivongs, Oliver Bezencon